Drugs that contain Olanzapine Pamoate
1. Zyprexa Relprevv patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6169084 | CHEPLAPHARM | 2-methyl-thieno-benzodiazepine formulation |
Sep, 2018
(5 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Dec 11, 2012 |
Market Authorisation Date: 11 December, 2009
Treatment: A method of treating human suffering from or susceptible to psychosis.
Dosage: SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
More Information on Dosage
ZYPREXA RELPREVV family patents
